Sickle cell anemia and pregnancy: a clinical case report
DOI:
https://doi.org/10.18270/rsb.v9i2.2809Keywords:
Anemia, Sickle Cell, Hemoglobin, Sickle, Pregnancy Complications, Pregnancy Outcome, Pregnancy, High-Risk, Maternal Mortality, Perinatal Mortality, Preeclampsia, MorbidityAbstract
Sickle cell anemia (SCA) is a pathology with high rates of complications, when presented in pregnancy it is a medical challenge to manage patients due to the high risk of maternal and perinatal morbidity-mortality, case report and review of literature presented at the Hospital Universitario Clínica San Rafael de Bogotá (National Clinic) in 2018, a women in the third trimester of pregnancy with diagnosis of sickle cell anemia that is complicated with preeclampsia with characteristics of severity and preterm delivery.
The objective of publishing this case is to review the information regarding the incidence, the maternal and perinatal morbidity / mortality of this medical condition, its management by a multidisciplinary team and the early detection of complications in order to improve the prognosis of the motherchild binomial.
Downloads
Download data is not yet available.
References
Rizk S, Pulte ED, Axelrod D, Ballas SK. Perinatal Maternal Mortality in Sickle Cell Anemia: Two Case Reports and Review of the Literature. Hemoglobin. 2017;41(4-6):225-9. DOI: 10.1080/03630269.2017.1397017.
Boafor TK, Olayemi E, Galadanci N, Hayfron-Benjamin C, Dei-Adomakoh Y, Segbefia C, et al. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. Obstetric Anesthesia Digest. 2017;37(1):9-10. DOI: 10.1097/01.aoa.0000511999.06517.f5.
Proudfit CL, Atta E, Doyle NM. Hemolytic Transfusion Reaction After Preoperative Prophylactic Blood Transfusion for Sickle Cell Disease in Pregnancy. Obstet Gynecol. 2007;110(2 Pt 2):471-4. DOI: 10.1097/01.AOG.0000258784.61584.f5.
Howard J, Oteng-Ntim E. The obstetric management of sickle cell disease. Best Pract Res Clin Obstet Gynaecol. 2012;26(1):25-36. DOI: 10.1016/j.bpobgyn.2011.10.001.
Jackson B, Fasano R, Roback J. Current Evidence for the Use of Prophylactic Transfusion to Treat Sickle Cell Disease During Pregnancy. Transfusion Medicine Reviews. 2018;32(4):220-224. DOI: 10.1016/j.tmrv.2018.06.001.
Boga C, Ozdogu H. Pregnany and sickle cell disease: A review of the current literature. Crit Rev Oncol Hematol. 2016;98:364-74. DOI: 10.1016/j.critrevonc.2015.11.018.
Patil V, Ratnayake G, Fastovets G. Clinical ‘pearls’ of maternal critical care Part 2: sickle- cell disease in pregnancy. Curr Opin Anesthesiol. 2017;30(3):326-34. DOI: 10.1097/ACO.0000000000000464.
Pujadas-Rios X, Viñals-Rodríguez LL. Enfermedad de células falciformes en el embarazo. Revista Cubana de Obstetricia y Ginecología. 2016;42(2):239-53.
Parrish MR, Morrison JC. Sickle cell crisis and pregnancy. Semin Perinatol. 2013;37(4):274-9. DOI: 10.1053/j.semperi.2013.04.006.
Okusanya BO, Oladapo OT. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. Cochrane Database Syst Rev. 2016;12:CD010378. DOI: 10.1002/14651858.CD010378.pub3.
Kuo K, Caughey AB. Contemporary outcomes of sickle cell disease in pregnancy. Am J Obstet Gynecol. 2016;215(4):505.e5. DOI: 10.1016/j.ajog.2016.05.032.
Costa VM, Viana MB, Agugiar RA. Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes. J Matern Fetal Neonatal Med. 2015;28(6):685-9. DOI: 10.3109/14767058.2014.928855.
Alayed N, Kezouh A, Oddy L, Abenhaim HA. Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births. J Perinat Med. 2014;42(4):487-92. DOI: 10.1515/jpm-2013-0275.
Asnani MR, McCaw-Binns AM, Reid ME. Excess risk of maternal death from sickle cell disease in Jamaica: 1998-2007. PloS One. 2011;6(10):e26281. DOI: 10.1371/journal.pone.0026281.
Andemariam B, Browning SL. Current Management of Sickle Cell Disease in Pregnancy. Clin Lab Med. 2013;33(2):293-310. DOI: 10.1016/j.cll.2013.03.023.
Rogers DT, Molokie R. Sickle Cell Disease in Pregnancy. Obstetr Gynecol Clin North Am. 2010;37(2):223-37. DOI: 10.1016/j.ogc.2010.02.015.
Noubouossie D, Key NS. Sickle cell disease and venous thromboembolism in pregnancy and the puerperium. Thromb Res. 2015;135(Suppl 1):S46-8. DOI: 10.1016/S00493848(15)50442-8.
Hathaway AR. Sickle Cell Disease in Pregnancy. South Med J. 2016;109(9):554-6. DOI: 10.14423/SMJ.0000000000000514.
Nevitt SJ, Jones AP, Howard J. Hydroxyurea (hydroxycarbamide) for sickle cell disease. Cochrane Database Syst Rev. 2017;4:CD002202. DOI: 10.1002/14651858.CD002202.pub2.
Boafor TK, Olayemi E, Galadanci N, Hayfron-Benjamin C, Dei-Adomakoh Y, Segbefia C, et al. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. Obstetric Anesthesia Digest. 2017;37(1):9-10. DOI: 10.1097/01.aoa.0000511999.06517.f5.
Proudfit CL, Atta E, Doyle NM. Hemolytic Transfusion Reaction After Preoperative Prophylactic Blood Transfusion for Sickle Cell Disease in Pregnancy. Obstet Gynecol. 2007;110(2 Pt 2):471-4. DOI: 10.1097/01.AOG.0000258784.61584.f5.
Howard J, Oteng-Ntim E. The obstetric management of sickle cell disease. Best Pract Res Clin Obstet Gynaecol. 2012;26(1):25-36. DOI: 10.1016/j.bpobgyn.2011.10.001.
Jackson B, Fasano R, Roback J. Current Evidence for the Use of Prophylactic Transfusion to Treat Sickle Cell Disease During Pregnancy. Transfusion Medicine Reviews. 2018;32(4):220-224. DOI: 10.1016/j.tmrv.2018.06.001.
Boga C, Ozdogu H. Pregnany and sickle cell disease: A review of the current literature. Crit Rev Oncol Hematol. 2016;98:364-74. DOI: 10.1016/j.critrevonc.2015.11.018.
Patil V, Ratnayake G, Fastovets G. Clinical ‘pearls’ of maternal critical care Part 2: sickle- cell disease in pregnancy. Curr Opin Anesthesiol. 2017;30(3):326-34. DOI: 10.1097/ACO.0000000000000464.
Pujadas-Rios X, Viñals-Rodríguez LL. Enfermedad de células falciformes en el embarazo. Revista Cubana de Obstetricia y Ginecología. 2016;42(2):239-53.
Parrish MR, Morrison JC. Sickle cell crisis and pregnancy. Semin Perinatol. 2013;37(4):274-9. DOI: 10.1053/j.semperi.2013.04.006.
Okusanya BO, Oladapo OT. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. Cochrane Database Syst Rev. 2016;12:CD010378. DOI: 10.1002/14651858.CD010378.pub3.
Kuo K, Caughey AB. Contemporary outcomes of sickle cell disease in pregnancy. Am J Obstet Gynecol. 2016;215(4):505.e5. DOI: 10.1016/j.ajog.2016.05.032.
Costa VM, Viana MB, Agugiar RA. Pregnancy in patients with sickle cell disease: maternal and perinatal outcomes. J Matern Fetal Neonatal Med. 2015;28(6):685-9. DOI: 10.3109/14767058.2014.928855.
Alayed N, Kezouh A, Oddy L, Abenhaim HA. Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births. J Perinat Med. 2014;42(4):487-92. DOI: 10.1515/jpm-2013-0275.
Asnani MR, McCaw-Binns AM, Reid ME. Excess risk of maternal death from sickle cell disease in Jamaica: 1998-2007. PloS One. 2011;6(10):e26281. DOI: 10.1371/journal.pone.0026281.
Andemariam B, Browning SL. Current Management of Sickle Cell Disease in Pregnancy. Clin Lab Med. 2013;33(2):293-310. DOI: 10.1016/j.cll.2013.03.023.
Rogers DT, Molokie R. Sickle Cell Disease in Pregnancy. Obstetr Gynecol Clin North Am. 2010;37(2):223-37. DOI: 10.1016/j.ogc.2010.02.015.
Noubouossie D, Key NS. Sickle cell disease and venous thromboembolism in pregnancy and the puerperium. Thromb Res. 2015;135(Suppl 1):S46-8. DOI: 10.1016/S00493848(15)50442-8.
Hathaway AR. Sickle Cell Disease in Pregnancy. South Med J. 2016;109(9):554-6. DOI: 10.14423/SMJ.0000000000000514.
Nevitt SJ, Jones AP, Howard J. Hydroxyurea (hydroxycarbamide) for sickle cell disease. Cochrane Database Syst Rev. 2017;4:CD002202. DOI: 10.1002/14651858.CD002202.pub2.
Downloads
Published
2019-12-13
How to Cite
Guzmán-Yara, Y. N., Sánchez-Gutiérrez, S. M., Castaño_Bermúdez, M. J., Flórez_Ruiz, G., Falla Morán, I. S., Archila-Pérez, D., & Romero-Sánchez, D. A. (2019). Sickle cell anemia and pregnancy: a clinical case report. Revista Salud Bosque, 9(2), 65–72. https://doi.org/10.18270/rsb.v9i2.2809
Issue
Section
Case report:
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors will submit a statement attesting to the authenticity of the material, attaching signature and id number. It is also required that they submit a statement surrendering economic rights to El Bosque University
